Over 1200 cases of carcinoma of the gastric remnant have been reported in the literature. There is an increase of this type of carcinoma in postoperative stomachs with atrophic gastritis and intestinal metaplasia. The cause and effect relationships remain to be fully elucidated. In patients with late postgastrectomy symptoms, carcinoma of the gastric remnant should be considered in the differential diagnosis. In a study of 350 asymptomatic patients who were more than 20 years from Billroth II gastric resection, 14 carcinomas were discovered in the region of the stoma. Preoperatively, gross endoscopic appearance and multiple biopsies will usually provide the diagnosis. At the time of revisional surgery, frozen section of gastric biopsies or the resected specimen may be necessary to exclude the diagnosis. At present there is widespread interest in several procedures in the treatment of benign ulcer disease. In selected patients, proximal gastric vagotomy is receiving particular interest. It remains to be determined what, if any, gastric mucosal alterations occur. Since the pyloric mechanism is intact, no stoma is created and no portion of the stomach resected; long-term followup of these patients will be of interest. Information as to the cause of gastric remnant carcinoma can be forthcoming only by evaluation of all groups of patients requiring gastric surgery for benign disease. At the same time, further investigation of patients with gastric carcinoma without prior resection who have atrophic gastritis and intestinal metaplasia is also necessary. The histologic type of carcinoma that develops in the gastric remnant is usually more favorable for surgical cure than those seen in the intact stomach. This means that early diagnosis by radiologic and endoscopic study of postgastrectomy patients developing symptoms is highly desirable. Because of the long interval between gastrectomy and gastric remnant carcinoma these patients are often in the older age group. The location of the lesion in the remaining proximal stomach will nearly always require total gastrectomy. This plus the age factor means that the operative mortality will be rather high. We are unable to explain why in 22 years of observing postgastrectomy patients we have seen only one case of gastric remnant carcinoma. This patient was successfully treated by left transpleural transdiaphragmatic total gastrectomy with Roux-en-Y esophagojejunostomy. This method is particulary easy in the patient who has has an antecolic Billroth II gastrectomy. If the jejunum cannot be adequately mobilized through a radial incision extending laterally from the esophageal hiatus, we use a peripheral diaphragmatic incision in circumferential fashion. This gives excellent exposure of the upper abdominal contents and also preserves the phrenic nerve. As a result, ventilatory function of the left leaf of the diaphragm is preserved postoperatively.
文献中已报道了1200多例残胃癌病例。在患有萎缩性胃炎和肠化生的术后胃中,这类癌症有所增加。其因果关系仍有待充分阐明。对于胃切除术后出现晚期症状的患者,鉴别诊断时应考虑残胃癌。在一项对350例无症状患者的研究中,这些患者距离毕罗Ⅱ式胃切除术已超过20年,在吻合口区域发现了14例癌症。术前,内镜大体表现和多次活检通常可做出诊断。在再次手术时,可能需要对胃活检组织或切除标本进行冰冻切片检查以排除诊断。目前,对于几种治疗良性溃疡病的手术方法存在广泛关注。在特定患者中,近端胃迷走神经切断术尤其受到关注。胃黏膜会发生哪些改变(如果有改变的话)仍有待确定。由于幽门机制完好,无需造口,也无需切除胃的任何部分;对这些患者进行长期随访将很有意义。只有通过评估所有因良性疾病而需要进行胃手术的患者群体,才能了解残胃癌的病因。同时,对患有萎缩性胃炎和肠化生且未进行过胃切除的胃癌患者进行进一步研究也是必要的。残胃中发生的癌组织学类型通常比完整胃中所见的癌更有利于手术治愈。这意味着通过影像学和内镜检查对出现症状的胃切除术后患者进行早期诊断是非常可取的。由于胃切除与残胃癌之间的间隔时间较长,这些患者往往属于老年群体。病变位于剩余的近端胃,几乎总是需要进行全胃切除术。再加上年龄因素,这意味着手术死亡率会相当高。我们无法解释为什么在观察胃切除术后患者的22年里,我们只见过1例残胃癌。该患者通过左胸经膈肌全胃切除术加Roux-en-Y食管空肠吻合术成功治愈。对于曾行结肠前毕罗Ⅱ式胃切除术的患者,这种方法特别容易实施。如果通过从食管裂孔向外延伸的放射状切口不能充分游离空肠,我们采用环形的外周膈肌切口。这样可以很好地暴露上腹部脏器,还能保留膈神经。结果,术后左半膈肌的通气功能得以保留。